2026. Evaluation of Urinary hsa-miR-21-5p Expression as a Non-Invasive Biomarker for Prostate Cancer. Althea Medical Journal. 13, 1 (Feb. 2026), 59–64. DOI:https://doi.org/10.15850/amj.v13n1.4388.